TGM2 and cranioectodermal dysplasia: Adult CeD testing strategies comprise serology for anti‐tissue transglutaminase (tTG) and anti‐endomysial antibody (EMA), and histopathological examination of duodenal endoscopic biopsies, the latter remaining the diagnostic ‘gold standard’ [10, 11].